menu
    • menu

    Company profile for Jaguar Health

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is appr...
    Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Jaguar HealthUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    201 Mission Street, Suite 2375, San Francisco, CA 94105, US
    Telephone
    Telephone
    (415) 371-8300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://jaguar.health/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/jaguar-health/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jaguar Health Strengthens Global IP With New Crofelemer Patent
    Jaguar Health Strengthens Global IP With New Crofelemer Patent

    24 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-24/jaguar-health-secures-new-patent-for-crofelemer-in-short-bowel-syndrome-strengthening-global-ip-pos

    PHARMIWEB
    24 Nov 2025
    Share Share
    Jaguar Health Submits Amended Protocol To FDA For Crofelemer
    Jaguar Health Submits Amended Protocol To FDA For Crofelemer

    20 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-20/in-support-of-possible-expedited-approval-pathway-for-crofelemer-for-treatment-of-microvillus-inclus

    PHARMIWEB
    20 Nov 2025
    Share Share
    Jaguar Health Reports 4% Revenue Growth In Q3 2025
    Jaguar Health Reports 4% Revenue Growth In Q3 2025

    17 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-17/jaguar-health-reports-third-quarter-2025-financials-net-q3-2025-revenue-up-approximately-4-versus

    PHARMIWEB
    17 Nov 2025
    Share Share
    Jaguar Health Hosts Investor Webcast On Q3 2025 Financials Result
    Jaguar Health Hosts Investor Webcast On Q3 2025 Financials Result

    14 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-14/jaguar-health-to-hold-investor-webcast-monday-november-17-at-830-am-eastern-regarding-q3-2025-fina

    PHARMIWEB
    14 Nov 2025
    Share Share
    Jaguar Health Provides Recap of November 8, 2025 Presentation
    Jaguar Health Provides Recap of November 8, 2025 Presentation

    13 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-13/jaguar-health-provides-recap-of-november-8-2025-presentation-on-groundbreaking-results-of-proof-of

    PHARMIWEB
    13 Nov 2025
    Share Share
    Jaguar Health Unveils Crofelemer for Pediatric Intestinal Failure
    Jaguar Health Unveils Crofelemer for Pediatric Intestinal Failure

    06 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-06/reminder-initial-groundbreaking-results-of-proof-of-concept-study-of-jaguar-healths-crofelemer-for

    PHARMIWEB
    06 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search